EcoDrugPlus

Thromboxane A2 Receptor

Ensembl ID : ENSCMIG00000003678
Gene Symbol: TBXA2R
4 Cross references
194 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSCMIG00000004857
Gene Symbol: TYMP
3 Cross references
173 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSCMIG00000016184
Gene Symbol: TYMS
3 Cross references
224 Possible Orthologues:

Thyroid Hormone Receptor Alpha

Ensembl ID : ENSCMIG00000002447
Gene Symbol: LOC103172030
3 Cross references
392 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSCMIG00000015694
Gene Symbol: THRB
4 Cross references
387 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor B

Ensembl ID : ENSCMIG00000012986
Gene Symbol: TRHRB
1 Cross references
269 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSCMIG00000009917
Gene Symbol: TLR7
1 Cross references
197 Possible Orthologues:

Toll-Like Receptor 2

Ensembl ID : ENSCMIG00000009922
Gene Symbol: LOC103185499
4 Cross references
233 Possible Orthologues:

Toll-Like Receptor 2

Ensembl ID : ENSCMIG00000009919
Gene Symbol: TLR2
1 Cross references
233 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSCMIG00000009942
Gene Symbol: TAAR1
1 Cross references
600 Possible Orthologues:

Trace Amine Associated Receptor 12f

Ensembl ID : ENSCMIG00000009945
Gene Symbol: TAAR12F
1 Cross references
754 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSCMIG00000002219
Gene Symbol: TRPA1
3 Cross references
228 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).